PATENT CLAIM ANALYSIS

Application Number: 16205637
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["514", "751000"]

Abstract:
The present invention is directed to novel compounds of Formula (I), pharmaceutically acceptable salts or solvates thereof, and their use.

Claim (Index 31):
The compound according to  claim 24  selected from the group consisting of:\n N-[3-(benzylmethylamino)propyl]-4-chlorobenzensulfonamide, \n 4-(benzylmethylamino)-N-(4-chlorophenyl)butanamide, \n N-(4-chlorobenzyl)-3-(benzylmethylamino)propanamide, \n N-(4-nitrobenzyl)-3-(benzylmethylamino)propanamide, \n N-(4-cyanobenzyl)-3-(benzylmethylamino)propanamide, \n N-(2,4-dichlorobenzyl)-3-(benzylmethylamino)propanamide, \n N-(3-chlorobenzyl)-3-(benzylmethylamino)propanamide, and \n N-(4-chlorobenzyl)-3-(benzylmethylamino)propanamine.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 98.0
- Lexical Diversity: 1.04167
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15317742', '11829531', '11463825', '15109101', '11909144']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8139086432944822
- 35 USC 102 Novelty (BERT): 0.5832594779809984
- Combined Prediction Score: 0.7908437267631339
- Mean Citation Score: 334.06991000000005
- Max Citation Score: 502.98242
- Similarity Product: 425.1123180824065

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test